Have a personal or library account? Click to login
In Vitro Assessment of Gentamicin Cytotoxicity on the Selected Mammalian Cell Line (Vero cells) Cover

In Vitro Assessment of Gentamicin Cytotoxicity on the Selected Mammalian Cell Line (Vero cells)

Open Access
|Dec 2017

Abstract

The aim of this study was to evaluate the in vitro cytotoxicity of different concentrations (500-7500 μg/mL) of gentamicin - GENT (aminoglycoside antibiotic) on the selected mammalian cell line (Vero - cell line from African green monkey kidney). Analysis of the cell morphological changes was microscopically evaluated (magnification × 400). Quantification of Ca, Mg and total proteins was performed using spectrophotometry on device Rx Monza (Randox). Quantification of Na, K and Cl was performed on the automatic analyzer EasyLyte. The cell viability was assessed using the metabolic mitochondrial MTT test. Vero cells were able to survive at concentrations of 500 (89.21 %), 1000 (79.54 %) and 2000 μg/mL (34.59 %). We observed statistically significant decrease of vital cell content at concentrations of 2000, 4500, 7500 μg/mL against control group. Vero cell line slightly reacted to the presence of GENT but total proteins and mineral parameters were not significantly affected. Vero cells were highly sensitive to GENT with a significant decrease of viability at concentrations of 2000 and 4500 μg/mL (P < 0.001). Our data reveal that GENT has a significant cytotoxic and adverse effect on the cell viability.

Language: English
Page range: 111 - 116
Accepted on: Dec 1, 2017
Published on: Dec 29, 2017
Published by: Banat’s University of Agricultural Sciences and Veterinary Medicine “King Michael I of Romania\"
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2017 Anton Kovacik, Eva Tvrda, Diana Fulopova, Peter Cupka, Eva Kovacikova, Katarina Zbynovska, Peter Massanyi, published by Banat’s University of Agricultural Sciences and Veterinary Medicine “King Michael I of Romania\"
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.